CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
July 2014—OpGen launched a molecular-based test that can identify patients at risk for harboring serious disease-causing, antibiotic-resistant microbes, the Acuitas MDRO Gene Test. The test uses DNA amplification and detection technology to detect as many as seven genes from one patient sample—genes associated with deadly bacteria, including carbapenem-resistant enterobacteriaceae containing KPC, NDM-1, and OXA-48 genes—within 24 hours.
OpGen, 240-813-1284